Store your medication somewhere visible but safe
Unlike injectable formulations that typically require cold-chain storage, oral GLP-1RAs bypass refrigeration constraints, thereby reducing manufacturing and distribution costs and improving accessibility in resource-limited settings [73]
GLP-1 RAs have also been found to reduce the risk of acute and chronic kidney disease, cardiovascular events, liver disease, sepsis, and substance use disorders
More severe spectrum: Gastroparesis (HR ~1.6 vs other agents) [16] Functional obstruction (gastric or small bowel dilation without transition point) ED management: Behavioural strategies & dietary strategies: Smaller meals, Eating slowly, Avoiding high-fat foods, alcohol & carbonation, High fiber diet
These take longer to digest and compound the gastric emptying delay caused by GLP-1 medications
Sustainability after stopping the medication depends heavily on the behavioral and lifestyle changes established during treatment